Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
Scope Biosciences has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Scope Biosciences's investors include SHIFT Invest, OostNL, EIC Accelerator, Genome Diagnostics.
Scope Biosciences is headquartered in Wageningen, The Netherlands.
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
Scope Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scope Biosciences — Funding & Investors." VCBacked, June 16, 2025, https://www.vcbacked.co/company/scope-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Scope Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/scope-biosciences
{{cite web |title=Scope Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/scope-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated